Filtros de búsqueda

Lista de obras de Bruno A Cardoso

Acetylation drives hepatocyte nuclear factor 1β stability by blocking proteasome-mediated degradation

scientific article published on 07 December 2018

Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia.

artículo científico publicado en 2013

Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential.

artículo científico publicado en 2015

FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.

artículo científico publicado en 2015

From the outside, from within: Biological and therapeutic relevance of signal transduction in T-cell acute lymphoblastic leukemia

artículo científico publicado en 2017

Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells

artículo científico publicado en 2009

IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias

artículo científico publicado en 2011

Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia

artículo científico publicado en 2011

Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity

artículo científico publicado en 2016

PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability

artículo científico publicado en 2008

RAC1b overexpression stimulates proliferation and NF-kB-mediated anti-apoptotic signaling in thyroid cancer cells

artículo científico publicado en 2017

STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells

TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells

artículo científico publicado en 2011

The Bone Marrow-Mediated Protection of Myeloproliferative Neoplastic Cells to Vorinostat and Ruxolitinib Relies on the Activation of JNK and PI3K Signalling Pathways

artículo científico publicado en 2015

Vorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanisms

artículo científico publicado en 2013

Vorinostat synergizes with antioxidant therapy to target myeloproliferative neoplasms

scientific article published on 13 February 2019